Back to Results
First PageMeta Content
Private equity / Finance / Corporate Venture Capital / Kleiner Perkins Caufield & Byers / Investment / Venture capital / Financial economics


Abingworth Corporate Fact Sheet Dec 2014 A4.indd
Add to Reading List

Document Date: 2015-01-06 12:34:04

Open Document

File Size: 2,79 MB

Share Result on Facebook

City

Menlo Park / Boston / London / /

Company

Supernus Pharmaceuticals / Abingworth LLP / Abingworth Management Limited / GlaxoSmithKline / Paratek Pharmaceuticals / Galapagos / Aurora Biosciences / Amarin Corporation / /

Continent

Europe / /

Country

United States / United Kingdom / /

Currency

USD / /

Facility

Glaxo Institute / /

IndustryTerm

venture capital / public relations strategy / biotechnology / pharmaceutical industry / healthcare / finance / investment banking / healthcare sectors / healthcare team / late-stage venture capital / life science venture capital investment / biotechnology industry / healthcare markets / investment / banking / /

NaturalFeature

East Coast / West Coast / /

Organization

Glaxo Institute for Molecular Biology / Financial Conduct Authority / /

Person

Syntaxin Therapeutics / John Shields / Wilson Therapeutics / James Abell / John Heard / Andrew Sinclair / Sarah Shackelton / Victoria Stewart / Vincent Miles / Peter Goodfellow / Ken Haas / Stephen / Tim Haines / Joseph Anderson / Michael F. Bigham / Alex Asquith / Kurt von Emster / /

/

Position

Counsel / Advisor / Portfolio Manager / Close advisors / Executive Chairman / General Counsel / Managing Partner / executive chair / General Counsel and CFO / Executive / director of Chiasma / Senior Vice President for Discovery Research / Director of a number / CFO / specialist team of 16 professionals / /

ProvinceOrState

California / /

PublishedMedium

Molecular Biology / /

Region

East Coast / West Coast / continental Europe / /

Technology

Biotechnology / Epigenomics / /

URL

www.abingworth.com / /

SocialTag